Lakeshore Biopharma CO (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70 | 616 | 720 | 885 | 1,075 |
| TOTAL | $289 | $631 | $784 | $1,027 | $1,297 |
| Non-Current Assets | |||||
| Investments And Advances | 201,200 | 200,298 | 200,027 | 200,007 | 200,003 |
| TOTAL | $201,200 | $200,298 | $200,027 | $200,007 | $200,003 |
| Total Assets | $201,489 | $200,929 | $200,811 | $201,034 | $201,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 30 | 0 | 0 | 0 | 38 |
| Accrued Expenses | 600 | 391 | 133 | 143 | 73 |
| TOTAL | $630 | $391 | $133 | $143 | $110 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 206,825 | 211,306 | 12,869 | 220,209 | 223,608 |
| TOTAL | $206,825 | $211,306 | $12,869 | $220,209 | $223,608 |
| Total Liabilities | $207,455 | $211,698 | $213,002 | $220,352 | $223,718 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,575 | 2,575 | 2,575 | N/A | 2,575 |
| Common Shares | 1 | 1 | 200,001 | 1 | 1 |
| Retained earnings | -5,967 | -10,769 | -12,192 | -19,318 | -22,419 |
| Other shareholders' equity | 0 | 0 | -200,000 | 0 | 0 |
| TOTAL | $-5,966 | $-10,769 | $-12,191 | $-19,318 | $-22,418 |
| Total Liabilities And Equity | $201,489 | $200,929 | $200,811 | $201,034 | $201,300 |